Evidence map›Paper›PMID 42380610›Full record

ArticleMolecular psychiatry2026

BDNF-DT and BDNF-AS-DT: novel genes in the BDNF locus.

Svitlana V Bach, Giovanna Punzi, Nuri E Smith, Sreya Mukherjee, Joo Heon Shin, Qiang Chen, Geo Pertea, Leonardo Collado-Torres, Kristen R Maynard, Stephanie C Page and 5 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Update of
    2025
5 · Who and what money

Authors and funding

15 authors.

Svitlana V Bach *Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.
Giovanna Punzi *Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-7530-3880
Nuri E SmithLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8019-2086
Sreya MukherjeeLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.
Joo Heon ShinLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-5563-8605
Qiang ChenLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.
Geo PerteaLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.
Leonardo Collado-TorresLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.
Kristen R MaynardLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-0031-8468
Stephanie C PageLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1951-7398
Joel E KleinmanLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-4210-6052
Thomas M HydeLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8746-3037
Daniel R WeinbergerLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2409-2969
Keri MartinowichLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA. keri.martinowich@libd.org.ORCID http://orcid.org/0000-0002-5237-0789
Gianluca UrsiniLieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA. gianluca.ursini@libd.org.ORCID http://orcid.org/0000-0002-4733-5196

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
Project 3P50MH136297 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Akira Sawa · 2024 to 2026
$12.8M
Regulation of neural activity in fear circuits by promoter IV derived BDNFR01MH105592 · NIMH · LIEBER INSTITUTE, INC. · PI MARTINOWICH, KERI · 2015 to 2024
$5.6M
Comprehensive Human Expressed Sequences in Brain (CHESS-BRAIN) and their roles in neuropsychiatric illnessR01MH123567 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SALZBERG, STEVEN L. · 2021 to 2025
$2.8M
NIMH NIH HHS P50 MH094268NIMH NIH HHS P50 MH136297NIMH NIH HHS R01 MH105592NIMH NIH HHS R01 MH123567U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) P50MH094268U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) P50MH136297U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH123567U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) RO1MH105592
6 · The paper itself

Abstract

Divergent transcription from bidirectional promoters is frequently observed in eukaryotic genomes, but the biological relevance of divergent RNA transcripts (DT) is unknown. We identified and characterized BDNF-DT, a novel DT gene, and BDNF-AS-DT, a novel readthrough gene, in the locus containing BDNF, a gene with key roles in neuronal development, differentiation, and synaptic plasticity. BDNF-DT is independent from the known BDNF antisense (BDNF-AS), and its expression is developmentally regulated and positively correlated with BDNF in human postmortem dorsolateral prefrontal cortex (DLPFC). BDNF-DT and BDNF-AS-DT expression increase after induced depolarization, but the temporal dynamics follow expression of BDNF, suggesting a regulatory role. Moreover, CRISPR-mediated upregulation of BDNF in human neural progenitor cells drives BDNF-DT expression. Finally, BDNF-DT shows higher expression in DLPFC from patients diagnosed with schizophrenia compared to neurotypical controls, and genetically predicted lower expression of the BDNF-AS-DT readthrough transcript is associated with schizophrenia and with the schizophrenia-associated C allele of the rs6265 single-nucleotide polymorphism. These findings identify BDNF-DT and BDNF-AS-DT as novel, low-abundance genes that show coordinated expression with BDNF and association with schizophrenia risk, though their biological significance requires further validation given detection limitations and the need to establish causal roles.

Indexed as

Brain-Derived Neurotrophic FactorDorsolateral Prefrontal CortexFemaleHumansMaleNeural Stem CellsNeuronal PlasticityPolymorphism, Single NucleotidePrefrontal CortexRNA, AntisenseSchizophreniaBDNF protein, humanBrain-Derived Neurotrophic FactorRNA, Antisense

Identifiers

PMID42380610
PMCPMC13569461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.